AEMD logo

AEMDAethlon Medical Inc

$2.02
$0.12
(6.32%)
Today
Closed $2.02
$0.02
(0.99%)
After Hours
Updated: 07:59 PM EDT
Reported EarningsJun 10
Mkt Cap$4.79M
Vol384,531.00
News
all
press releases
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update PR Newswire SAN DIEGO, June 10, 2026 Australian oncology study advances into Cohort 3 as enrollment...
PR Newswire
News Placeholder
More News
News Placeholder
The Next Meme Stock Wave?
A fresh wave of speculative activity swept through the small-cap market this week as traders piled into a combination of AI-linked companies, China-based growth stories, and emerging defense contractors. $BLIS, $GMM, $PAVS, $AEMD, $PAYO, $AZI, $CGTL, $CCSC, $ELPW, $JZXN, $MTEN
24-7 Market News
News Placeholder
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 PR Newswire SAN DIEGO, June 2, 2026 SAN DIEGO, June 2, 2026 /PRNewswire/ --Aethlon Medical...
PR Newswire
News Placeholder
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness PR Newswire SAN DIEGO, May 21, 2026 SAN DIEGO, May 21, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ...
PR Newswire
News Placeholder
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive...
PR Newswire
News Placeholder
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities PR Newswire SAN DIEGO, March 12, 2026 SAN...
PR Newswire
News Placeholder
Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026
Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 PR Newswire SAN DIEGO, Feb. 23...
PR Newswire
News Placeholder
Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update PR Newswire SAN DIEGO, Feb. 12, 2026...
PR Newswire
News Placeholder
Why Did Aethlon Medical Stock Tumble Over 12% Today?
Aethlon Medical's stock drew investor attention after the company announced a private placement and warrant inducement deal.
Stocktwits
News Placeholder
Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million Aethlon Medical Announces Pricing of a Private...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.